Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the thirteen brokerages that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average 12-month […]
More Stories
Appeals Court Allows Trump Admin Effort Targeting Noncitizen Voting
By Zachary Stieber A federal appeals court on Nov. 3 reinstated a decision that stays a restraining order that had...
US Manufacturing Expands for 10th Straight Month Amid High Input Costs
By Bill Pan U.S. manufacturing activity strengthened in October as new orders increased, although raw materials became more expensive and...
America Votes: What to Expect
By Lawrence Wilson Democrats appear poised to win control of the House and possibly the Senate on Nov. 3 as...
One Canadian Confirmed Among 69 Victims of Fatal Spanish Train Crash
By Jennifer Cowen Global Affairs has confirmed one Canadian was killed in last week’s high-speed rail collision in Spain. Sixty-nine...
All of Us Are Dead Season 2: Recent Updates and Cast Members
After letting fans wait for almost 4 years, All of Us Are Dead is getting ready for the continuation of...
US Took Enforcement Action Against 2.2 Million Illegal Immigrants, Officials Say
By Jack Phillips U.S. immigration officials say that the second Trump administration has moved to terminate or revoke the status...